PMC10062072_01
(a-l): Slit-lamp images for corneal status. Case 1: (a-c), case 2: (d-f), case 3: (g-i), and case 4: ((j-l)). First row before REE manifestation prenetarsudil, middle row with netarsudil-induced REE (fluorescein stain pattern of REE as inset pictures for case 2: (e and case 3: h) and bottom row post REE clearance on cessation of netarsudil for all cases, respectively (except 1l, case 4)
OJO-16-94-g001.jpg
PMC10062072_03_OJO-16-94-g001.jpg
F1
RE V/A was 6/36 (patchy capsular opacification) with partial stromal edema clearance compared to CF 4-m prenetarsudil therapy [Figure 1j-l].
PMC10062072_02
(a-l): Slit-lamp images for corneal status. Case 1: (a-c), case 2: (d-f), case 3: (g-i), and case 4: ((j-l)). First row before REE manifestation prenetarsudil, middle row with netarsudil-induced REE (fluorescein stain pattern of REE as inset pictures for case 2: (e and case 3: h) and bottom row post REE clearance on cessation of netarsudil for all cases, respectively (except 1l, case 4)
OJO-16-94-g001.jpg
PMC10062072_03_OJO-16-94-g001.jpg
F1
RE V/A was 6/36 (patchy capsular opacification) with partial stromal edema clearance compared to CF 4-m prenetarsudil therapy [Figure 1j-l].
PMC10062072_03
(a-l): Slit-lamp images for corneal status. Case 1: (a-c), case 2: (d-f), case 3: (g-i), and case 4: ((j-l)). First row before REE manifestation prenetarsudil, middle row with netarsudil-induced REE (fluorescein stain pattern of REE as inset pictures for case 2: (e and case 3: h) and bottom row post REE clearance on cessation of netarsudil for all cases, respectively (except 1l, case 4)
OJO-16-94-g001.jpg
PMC10062072_03_OJO-16-94-g001.jpg
F1
RE V/A was 6/36 (patchy capsular opacification) with partial stromal edema clearance compared to CF 4-m prenetarsudil therapy [Figure 1j-l].